Deliver within 90 minutes*
UK Registered Pharmacy
Discreet, Confidential Service
Shingles Vaccine
Shingrix is a recombinant zoster vaccine designed to prevent shingles (herpes zoster) and its complications. It is approved for adults aged 50 and older, as well as immunocompromised individuals aged 18 and older. Shingrix works by stimulating a strong immune response to the varicella-zoster virus, which causes shingles. The vaccine is administered in two doses, given 2 to 6 months apart. Clinical studies have shown Shingrix to be over 90% effective in preventing shingles and its painful complications, making it a highly recommended option for adults to protect against this condition.
Select Generic Or Branded
Select Legal Status
Select Strength
1
What is Shingrix?
Shingrix is a recombinant vaccine designed to prevent shingles (herpes zoster) and its complications, such as postherpetic neuralgia (PHN).
Who should get the Shingrix vaccine?
- Adults aged 50 and older: Recommended to prevent shingles and related complications.
- Immunocompromised individuals aged 18 and older: Approved to provide protection for those with weakened immune systems.
How is Shingrix administered?
Shingrix is given in two doses:
- First dose: Initial vaccination.
- Second dose: Administered 2 to 6 months after the first dose.
How effective is Shingrix?
Clinical studies indicate that Shingrix is over 90% effective in preventing shingles and its complications.
What are the common side effects of Shingrix?
Common side effects, typically mild to moderate in intensity, include:
- Pain, redness, and swelling at the injection site
- Muscle pain
- Fatigue
- Headache
- Fever
These side effects generally resolve within a few days.
Who should not receive the Shingrix vaccine?
- Individuals with a history of severe allergic reaction to any component of the vaccine.
- Those who have an active shingles infection.
- People with a fever of 38.5°C (101.3°F) or higher should wait until they recover before getting vaccinated.
How long does the protection from Shingrix last?
Current data suggests that Shingrix provides strong protection against shingles for at least four years. Ongoing studies are evaluating the long-term efficacy of the vaccine.
Is Shingrix safe for immunocompromised individuals?
Yes, Shingrix is approved and recommended for immunocompromised individuals aged 18 and older. Clinical trials have shown it to be safe and effective in this population.